Pixie Dust Technologies

Pixie Dust Technologies

Electromedical & Electrotherapeutic Apparatus

Company website

About

The company develops and markets innovative consumer personal care products and spatial materials through the use of mechanobiology and metamaterials combined with our core patented wave technology that utilizes sound and light waves. The company owns a broad portfolio of brands that are popular not only in Japan but also in many other countries around the world. In the last 6 months alone, retail sales of 3 products have been launched: - SonoRepro, a scalp care device with ultrasonic non-contact vibrotactile stimulation, November 2022; - VUEVO, a series of directional voice arrival detection devices for the deaf and hard of hearing ("DHH") in March 2023; and - kikippa, an acoustic stimulation device that functions as a speaker, April 2023. In addition to selling its own products, the company also owns a retail chain that sells third-party medical products and devices. Number of employees: 100 - 200 Headquarters: 2-20-5 Kanda Misaki-cho, Chiyoda-ku Tokyo, 101-0061, Japan Tel: +81(0)3-5244-4880


2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.